Impact of a clinical decision support system for drug dosage in patients with renal failure
- 357 Downloads
Background A clinical decision support system (CDSS) linked to the computerized physician order entry may help improve prescription appropriateness in inpatients with renal insufficiency. Objective To evaluate the impact on prescription appropriateness of a CDSS prescriber alert for 85 drugs in renal failure patients. Setting Before-after study in a 975-bed academic hospital. Method Prescriptions of patients with renal failure were reviewed during two comparable periods of 6 days each, before and after the implementation of the CDSS (September 2009 and 2010). Main outcome measure The proportion of inappropriate dosages of 85 drugs included in the CDSS was compared in the pre- and post-implementation group. Results Six hundred and fifteen patients were included in the study (301 in pre- and 314 in post-implementation periods). In the pre- and post-implementation period, respectively 2882 and 3485 prescriptions were evaluated, of which 14.9 and 16.6% triggered an alert. Among these, the dosage was inappropriate in respectively 25.4 and 24.6% of prescriptions in the pre- and post-implementation periods (OR 0.97; 95% CI 0.72–1.29). The most frequently involved drugs were paracetamol, perindopril, tramadol and allopurinol. Conclusion The implementation of a CDSS did not significantly reduce the proportion of inappropriate drug dosages in patients with renal failure. Further research is required to investigate the reasons why prescribers override alerts. Collaboration with clinical pharmacists might improve compliance with the CDSS recommendations.
KeywordsPrescription alerts Decision support systems Inappropriate prescribing Physician order entry system Medication error Renal insufficiency
The authors would like to thank M. Demey (IT department) for the development of the CDSS at the Cliniques universitaires Saint-Luc, Brussels, S. Thevelin and V. Mohymont.
No specific funding was received for this research.
Conflicts of interest
None. The authors have no conflicts of interest that are directly relevant to the content of this article.
- 1.Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Phys. 2007;75(10):1487–96.Google Scholar
- 14.Nuckols TKS-SC, Smith-Spangler C, Morton SC, Asch SM, Patel VM, Anderson LJ, et al. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis. Syst Rev. 2014;4(3):56.CrossRefGoogle Scholar
- 17.SPC. Summary of product characteristics. www.fagg-afmpsbe. Accessed 15 May 2017.
- 18.Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA et al. Drug prescribing in renal failure, dosing guidelines for adults. American College of Physicians. 2007. ISBN: 978-1-930513-76-1.Google Scholar
- 19.Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug information handbook. 2009–2010. ISBN 13: 978-1-591952-54-1.Google Scholar
- 29.Scheepers-Hoeks AM, Grouls RJ, Neef C, Korsten HH. Strategy for implementation and first results of advanced clinical decision support in hospital pharmacy practice. Stud Health Technol Inf. 2009;148:142–8.Google Scholar
- 31.Czock D, Konias M, Seidling HM, Kaltschmidt J, Schwenger V, Zeier M, et al. Tailoring of alerts substantially reduces the alert burden in computerized clinical decision support for drugs that should be avoided in patients with renal disease. J Am Med Inf Assoc (JAMIA). 2015;22(4):881–7.CrossRefGoogle Scholar